$MEDP News
Last published 2w ago
- 2w agoMEDPQ3 2026 Medpace Holdings, Inc. Earnings Conference Call - MEDPACE HOLDINGS INCEarnings Call TranscriptsGood day, ladies and gentlemen, and welcome to the MedPace 3rd Quarter 2026 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speaker's remarks, there will be a question-and-an
- 3w agoMEDPMedpace Holdings, Inc. Reports Third Quarter 2026 ResultsBusiness WireRevenue of $716.0 million in the third quarter of 2026 increased 8.5% from revenue of $659.9 million for the comparable prior-year period, representing a backlog conversion rate of 23.8%. Net new business awards
- 1mo agoMEDPMedpace Holdings, Inc. to Report Third Quarter 2026 Financial Results on October 21, 2026Business WireMedpace Holdings, Inc. (NASDAQ:MEDP) ("Medpace") today announced that it will report its third quarter 2026 financial results after the market close on Wednesday, October 21, 2026. The Company will host a
- 2mo agoINVINVWMAGNNOK+3Innventure Announces Board Leadership Changes to Further Enhance Board Independence and Acceleration of CEO TransitionGlobeNewswireBruce Brown Appointed as Chairman of the Innventure Board Catriona Fallon Publicly Named as Audit Committee Chair Dr. William Grieco Assumes CEO and Director Roles Effective September 1, 2026 Announces Ongoing Search
- 3mo agoMEDPKuehn Law Encourages Investors of Medpace Holdings, Inc. to Contact Law FirmPR NewswireKuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Medpace Holdings, Inc. (NASDAQ: MEDP)...
- 3mo agoMEDPQ2 2026 Medpace Holdings, Inc. Earnings Conference Call - MEDPACE HOLDINGS INCEarnings Call TranscriptsGood day, ladies and gentlemen, and welcome to the MedPace second quarter 2026 earnings conference call. At this time, all participants are in a listen-only mode. After the speaker's remarks, there will be a question and
- 3mo agoMEDPMedpace Holdings, Inc. Reports Second Quarter 2026 ResultsBusiness WireRevenue of $707.3 million in the second quarter of 2026 increased 17.2% from revenue of $603.3 million for the comparable prior-year period, representing a backlog conversion rate of 24.1%. Net new business awards
- 4mo agoMEDPMedpace Holdings, Inc. to Report Second Quarter 2026 Financial Results on July 22, 2026Business WireMedpace Holdings, Inc. (NASDAQ:MEDP) ("Medpace") today announced that it will report its second quarter 2026 financial results after the market close on Wednesday, July 22, 2026. The Company will host a conference call
- 6mo agoMEDPANNUAL MEETING OF STOCKHOLDERS - MEDPACE HOLDINGS INCEarnings Call TranscriptsWelcome and good day. I'm August Trundle, Chairman of the Board and Chief Executive Officer of MedBase and Chairman of today's meeting. Welcome to the 2026 MedBASE Annual Meeting of Stockholders. We are conducting this y
- 6mo agoHTGCMDBMEDPNUAIAttention Long-Term Shareholders of Hercules Capital Inc. (NYSE: HTGC); New Era Energy & Digital, Inc. (NASDAQ: NUAI); Medpace Holdings, Inc. (NASDAQ: MEDP); and MongoDB Inc. (NASDAQ: MDB): Grabar Law Office Investigates Claims on Your BehalfGlobeNewswirePHILADELPHIA, May 14, 2026 (GLOBE NEWSWIRE) -- HERCULES CAPITAL INC. (NYSE:HTGC): WHAT IS HAPPENING? Grabar Law Office is investigating claims on behalf of shareholders of Hercules Capital Inc. (NYSE:HTGC). The
- 6mo agoMEDPNUAISWKSUPSTImportant Notice to Long-Term Shareholders of Medpace Holdings, Inc. (NASDAQ: MEDP); New Era Energy & Digital, Inc. (NASDAQ: NUAI); Skyworks Solutions, Inc. (NASDAQ: SWKS); and Upstart Holdings, Inc. (NASDAQ: UPST): Grabar Law Office Investigates Claims on Your BehalfGlobeNewswirePHILADELPHIA, May 11, 2026 (GLOBE NEWSWIRE) -- Medpace Holdings, Inc. (NASDAQ:MEDP): What is Happening? Grabar Law Office is investigating claims on behalf of shareholders of Medpace Holdings, Inc. (NASDAQ:MEDP).
- 6mo agoMEDPMedpace Holdings, Inc. Reports First Quarter 2026 ResultsBusiness WireRevenue of $706.6 million in the first quarter of 2026 increased 26.5% from revenue of $558.6 million for the comparable prior-year period, representing a backlog conversion rate of 23.3%. Net new business awards
- 7mo agoMEDPMedpace Holdings, Inc. to Report First Quarter 2026 Financial Results on April 22, 2026Business WireMedpace Holdings, Inc. (NASDAQ:MEDP) ("Medpace") today announced that it will report its first quarter 2026 financial results after the market close on Wednesday, April 22, 2026. The Company will host a conference call
- 9mo agoMEDPQ4 2025 Medpace Holdings, Inc. Earnings Conference Call - MEDPACE HOLDINGS INCEarnings Call TranscriptsGood day ladies and gentlemen and welcome to the MedPace fourth quarter and full year 2025 earnings conference call. At this time all participants are in a lesson only mode. After the speaker's remarks there will be a qu
- 9mo agoMEDPMedpace Holdings, Inc. Reports Fourth Quarter and Full Year 2025 ResultsBusiness WireRevenue of $708.5 million in the fourth quarter of 2025 increased 32.0% from revenue of $536.6 million for the comparable prior-year period, representing a backlog conversion rate of 23.6%. Net new business awards
- 10mo agoMEDPMedpace Holdings, Inc. to Report Fourth Quarter and Fiscal Year 2025 Financial Results on February 9, 2026Business WireMedpace Holdings, Inc. (NASDAQ:MEDP) ("Medpace") today announced that it will report its fourth quarter and fiscal year 2025 financial results after the market close on Monday, February 9, 2026. The Company will host a
- 1y agoMEDPQ3 2025 Medpace Holdings, Inc. Earnings Conference Call - MEDPACE HOLDINGS INCEarnings Call TranscriptsGood day, ladies and gentlemen, and welcome to the MedPace 3rd Quarter 2025 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speaker's remarks, there will be a question-and-an
- 1y agoMEDPMedpace Holdings, Inc. Reports Third Quarter 2025 ResultsBusiness WireRevenue of $659.9 million in the third quarter of 2025 increased 23.7% from revenue of $533.3 million for the comparable prior-year period, representing a backlog conversion rate of 23.0%. Net new business awards
- 1y agoMEDPADVANCING OBESITY CLINICAL DEVELOPMENT: EMERGING STRATEGIES FOR NEXT‑GEN TRIALS - MedpaceEarnings Call TranscriptsGood day and welcome to everyone joining us and welcome to today's Xtalks webinar. Today's talk is entitled Advancing Obesity Clinical Development, Emerging Strategies for Next Gen Trials. My name is Aisha Rashid and I'l
- 1y agoMEDPMedpace Holdings, Inc. to Report Third Quarter 2025 Financial Results on October 22, 2025Business WireMedpace Holdings, Inc. (NASDAQ:MEDP) ("Medpace") today announced that it will report its third quarter 2025 financial results after the market close on Wednesday, October 22, 2025. The Company will host a conference
- 1y agoMEDPMedpace Holdings, Inc. Reports Second Quarter 2025 ResultsBusiness WireRevenue of $603.3 million in the second quarter of 2025 increased 14.2% from revenue of $528.1 million for the comparable prior-year period, representing a backlog conversion rate of 21.2%. Net new business awards
- 1y agoMEDPMedpace Holdings, Inc. to Report Second Quarter 2025 Financial Results on July 21, 2025Business WireMedpace Holdings, Inc. (NASDAQ:MEDP) ("Medpace") today announced that it will report its second quarter 2025 financial results after the market close on Monday, July 21, 2025. The Company will host a conference call the
- 1y agoMEDPMedpace Holdings, Inc. Reports First Quarter 2025 ResultsBusiness WireRevenue of $558.6 million in the first quarter of 2025 increased 9.3% from revenue of $511.0 million for the comparable prior-year period, representing a backlog conversion rate of 19.2%. Net new business awards were
- 1y agoMEDPMedpace Holdings, Inc. to Report First Quarter 2025 Financial Results on April 21, 2025Business WireMedpace Holdings, Inc. (NASDAQ:MEDP) ("Medpace") today announced that it will report its first quarter 2025 financial results after the market close on Monday, April 21, 2025. The Company will host a conference call the
- 1y agoMEDPMedpace Holdings, Inc. Reports Fourth Quarter and Full Year 2024 ResultsBusiness WireRevenue of $536.6 million in the fourth quarter of 2024 increased 7.7% from revenue of $498.4 million for the comparable prior-year period, representing a backlog conversion rate of 18.3%. Net new business awards
- 1y agoMEDPMedpace Holdings, Inc. to Report Fourth Quarter and Fiscal Year 2024 Financial Results on February 10, 2025Business WireMedpace Holdings, Inc. (NASDAQ:MEDP) ("Medpace") today announced that it will report its fourth quarter and fiscal year 2024 financial results after the market close on Monday, February 10, 2025. The Company will host a
- 2y agoMEDPMedpace Holdings, Inc. (MEDP) Q3 2024 Earnings Call TranscriptEarnings Call Transcripts
- 2y agoMEDPMedpace Holdings, Inc. Reports Third Quarter 2024 ResultsBusiness WireRevenue of $533.3 million in the third quarter of 2024 increased 8.3% from revenue of $492.5 million for the comparable prior-year period, representing a backlog conversion rate of 18.2%. Net new business awards were
- 2y agoMEDPMedpace Holdings, Inc. to Report Third Quarter 2024 Financial Results on October 21, 2024Business WireMedpace Holdings, Inc. (NASDAQ:MEDP) ("Medpace") today announced that it will report its third quarter 2024 financial results after the market close on Monday, October 21, 2024. The Company will host a conference call
- 2y agoBERYECVTGLTHUT+6Berry and Glatfelter Announce Magnera Board of Director Appointments in Connection With Proposed Merger of Berry's Health, Hygiene and Specialties Global Nonwovens and Films Business With GlatfelterGlobeNewswireCHARLOTTE, N.C., Aug. 16, 2024 (GLOBE NEWSWIRE) -- Glatfelter Corporation (NYSE:GLT), and Berry Global Group, Inc. (NYSE:BERY) today announce additional director designees for the board of directors for the combined
- 2y agoMEDPKirby McInerney LLP Announces Investigation of Shareholder Claims Against Medpace Holdings, Inc. (MEDP)Business WireThe law firm of Kirby McInerney LLP is investigating potential claims against Medpace Holdings, Inc. ("Medpace" or the "Company") (NASDAQ:MEDP). The investigation concerns whether Medpace and/or certain of its officers
- 2y agoMEDPMedpace Holdings, Inc. (MEDP) Q2 2024 Earnings Call TranscriptEarnings Call Transcripts
- 2y agoMEDPMedpace Holdings, Inc. Reports Second Quarter 2024 ResultsBusiness WireRevenue of $528.1 million in the second quarter of 2024 increased 14.6% from revenue of $460.9 million for the comparable prior-year period, representing a backlog conversion rate of 18.2%. Net new business awards
- 2y agoMEDPMedpace Holdings, Inc. to Report Second Quarter 2024 Financial Results on July 22, 2024Business WireMedpace Holdings, Inc. (NASDAQ:MEDP) ("Medpace") today announced that it will report its second quarter 2024 financial results after the market close on Monday, July 22, 2024. The Company will host a conference call the
- 2y agoMEDPMedpace Holdings, Inc. (MEDP) Q1 2024 Earnings Call TranscriptEarnings Call Transcripts
- 2y agoMEDPMedpace Holdings, Inc. Reports First Quarter 2024 ResultsBusiness WireRevenue of $511.0 million in the first quarter of 2024 increased 17.7% from revenue of $434.1 million for the comparable prior-year period, representing a backlog conversion rate of 18.2%. Net new business awards
- 2y agoMEDPMedpace Holdings, Inc. to Report First Quarter 2024 Financial Results on April 22, 2024Business WireMedpace Holdings, Inc. (NASDAQ:MEDP) ("Medpace") today announced that it will report its first quarter 2024 financial results after the market close on Monday, April 22, 2024. The Company will host a conference call the
- 2y agoMEDPMedpace Holdings, Inc. (MEDP) Q4 2023 Earnings Call TranscriptEarnings Call Transcripts
- 2y agoMEDPMedpace Holdings, Inc. Reports Fourth Quarter and Full Year 2023 ResultsBusiness WireRevenue of $498.4 million in the fourth quarter of 2023 increased 26.5% from revenue of $394.1 million for the comparable prior-year period, representing a backlog conversion rate of 18.5%. Net new business awards
- 2y agoMEDPMedpace Holdings, Inc. to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 12, 2024Business WireMedpace Holdings, Inc. (NASDAQ:MEDP) ("Medpace") today announced that it will report its fourth quarter and fiscal year 2023 financial results after the market close on Monday, February 12, 2024. The Company will host a
- 3y agoMEDPMedpace Holdings, Inc. Reports Third Quarter 2023 ResultsBusiness WireRevenue of $492.5 million in the third quarter of 2023 increased 28.3% from revenue of $383.7 million for the comparable prior-year period, representing a backlog conversion rate of 19.1%. Net new business awards
- 3y agoMEDPMedpace Holdings, Inc. to Report Third Quarter 2023 Financial Results on October 23, 2023Business WireMedpace Holdings, Inc. (NASDAQ:MEDP) ("Medpace") today announced that it will report its third quarter 2023 financial results after the market close on Monday, October 23, 2023. The Company will host a conference call
- 3y agoMEDPMedpace Holdings, Inc. Reports Second Quarter 2023 ResultsBusiness WireRevenue of $460.9 million in the second quarter of 2023 increased 31.2% from revenue of $351.2 million for the comparable prior-year period, representing a backlog conversion rate of 18.7%. Net new business awards
- 3y agoMEDPMedpace Holdings, Inc. to Report Second Quarter 2023 Financial Results on July 24, 2023Business WireMedpace Holdings, Inc. (NASDAQ:MEDP) ("Medpace") today announced that it will report its second quarter 2023 financial results after the market close on Monday, July 24, 2023. The Company will host a conference call the
- 3y agoMEDPMedpace Holdings, Inc. Reports First Quarter 2023 ResultsBusiness WireRevenue of $434.1 million in the first quarter of 2023 increased 31.2% from revenue of $330.9 million for the comparable prior-year period, representing a backlog conversion rate of 18.6%. Net new business awards
- 3y agoMEDPMedpace Holdings, Inc. to Report First Quarter 2023 Financial Results on April 24, 2023Business WireMedpace Holdings, Inc. (NASDAQ:MEDP) ("Medpace") today announced that it will report its first quarter 2023 financial results after the market close on Monday, April 24, 2023. The Company will host a conference call the
- 3y agoMEDPMedpace Holdings, Inc. Reports Fourth Quarter and Full Year 2022 ResultsBusiness WireRevenue of $394.1 million in the fourth quarter of 2022 increased 27.7% from revenue of $308.6 million for the comparable prior-year period, representing a backlog conversion rate of 17.6%. Net new business awards
- 3y agoMEDPMedpace Holdings, Inc. to Report Fourth Quarter and Fiscal Year 2022 Financial Results on February 13, 2023Business WireMedpace Holdings, Inc. (NASDAQ:MEDP) ("Medpace") today announced that it will report its fourth quarter and fiscal year 2022 financial results after the market close on Monday, February 13, 2023. The Company will host a
- 3y agoMEDPAssessment of Safety, Tolerability and Drug Levels of NPM-119 in Participants With Type 2 Diabetes - NCT05670379ClinicalTrials.govArea under the plasma concentration-time curve (AUC), Maximum plasma concentration observed (Cmax), Time to maximum plasma concentration observed (Tmax), (and 3 more...)
- 4y agoMEDPMedpace Holdings, Inc. Reports Third Quarter 2022 ResultsBusiness WireRevenue of $383.7 million in the third quarter of 2022 increased 29.8% from revenue of $295.6 million for the comparable prior-year period, representing a backlog conversion rate of 17.7%. Net new business awards